BOSTON–(BUSINESS WIRE)–
908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today announced it will participate in the following investor conferences.
-
53rd Annual Baird Industrial Conference
In-person presentation only on Wednesday, November 8th at 10:35 a.m. Pacific Time / 1:35 a.m. Eastern Time -
Stifel Healthcare Conference 2023
Fireside chat on Tuesday, November 14th at 5 a.m. Pacific Time / 8 a.m. Eastern Time -
25th Annual Stephens Investment Conference
Fireside chat on Wednesday, November 15 at 6 a.m. Pacific Time / 9 a.m. Eastern Time
Interested parties may access a live and archived webcast of these sessions on the “Investors” section of the company website at: www.908devices.com.
About 908 Devices
908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, pharma/biopharma, forensics and adjacent markets. The Company is headquartered in the heart of Boston, where it designs and manufactures innovative products that bring together the power of mass spectrometry, microfluidic sampling and separations, software automation, and machine learning.
Media
Barbara Russo
[email protected]
Investor
Carrie Mendivil
[email protected]
Source: 908 Devices Inc.